-
News | 2015.04.29
The Médecine-Sciences Program: combining science and medicine to train tomorrow's leaders in biomedical research
Recent scientific breakthroughs and technological advances have fundamentally transformed the practice of medicine and biomedical research. To keep step with this changing environment, the École Normale Supérieure, the Institut Pasteur, the Institut Curie, ESPCI ParisTech, the Collège de France and PSL Research University have joined forces to offer students in medicine and pharmacy a new...
-
News | 2015.05.05
The Institut Pasteur and Stragen sign an exclusive worldwide license agreement for first-in-class pain management novel compound
The Institut Pasteur, a private non-profit international biomedical research center based in Paris (France), and Stragen, privately-owned, international healthcare company based in Geneva (Switzerland), announced today that they have entered together into an exclusive worldwide license for intellectual property, related to derivatives of endogenous dual enkephalinase inhibitor (DENKI) novel...
-
News | 2015.05.06
From monkeys to humans: the importance of interspecies transmission in the emergence of retroviruses in Central Africa
Most of the viral pathogenic agents that have emerged in humans in recent decades are of animal origin. Hence, researchers from the Institut Pasteur have recently proved, for the first time scientifically at the epidemiological level, that specific contact with a monkey is a risk factor for the transmission of a pathogenic retrovirus (STLV-1/HTLV-1) to humans
-
News | 2015.05.07
Viagra to prevent transmission of the malaria parasite?
By increasing the stiffness of erythrocytes infected by the causal agent of malaria, Viagra favors their elimination from the blood circulation and may therefore reduce transmission of the parasite from humans to mosquitoes. This astonishing discovery could lead to a treatment to reduce the spread of malaria within a population.
-
News | 2015.05.17
Premature aging: scientists identify and correct defects in diseased cells
Scientists have succeeded in restoring normal activity in cells isolated from patients with the premature aging disease Cockayne syndrome. They have uncovered the role played in these cells by an enzyme, the HTRA3 protease. This enzyme is overexpressed in Cockayne syndrome patient cells, and leads to mitochondrial defects, which in turn play a crucial role in the appearance of symptoms leading to...
-
News | 2015.05.18
Christian Bréchot at the Pasteur Institute of Côte d’Ivoire, a visit under the sign of modernization
Abidjan May 6, 2015 On the occasion of the first visit of the Director of the Institut Pasteur for 40 years, an honor guard welcomed Christian Bréchot and Marc Jouan on their arrival on the campus of the Institut Pasteur of Côte d'Ivoire The visit of the Institut Pasteur in Côte d'Ivoire has shown the dynamism of this institute which had joined the International Network of Pasteur...
-
News | 2015.05.21
EBOV sequences from Guinea
The Institut Pasteur and the Institut Pasteur International network are releasing EBOV sequences to support the public health response as well as the development and evaluation of EVD vaccines, therapeutics, and diagnostics. Please feel free to download, use, and analyze this data.
-
News | 2015.05.24
Dogma challenged: the genetic determination of testis or ovary is conserved through evolution
In animals, sexual reproduction is almost universal but the mechanisms that determine the choice between forming a testis or ovary are highly diverse. Researchers from the Institut Pasteur and the University of Minnesota have recently proven that the genetic determination of testis or ovary has been conserved through evolution, thanks to a study of the gene DMRT1.
-
News | 2015.05.25
The Minister of health of Mexico visited the Institut Pasteur
Prof. Christian Bréchot welcomed Ms. Mercedes Juan López, Mexico’s Minister of health, to the Pasteur Institute on Thursday, May 21st. They discussed the strengthening of our contacts and the renewal of partnership agreements which will be signed in July of this year during the visit of the Mexican President in Paris. At the delegation request they visited the genomic platform of the...
-
News | 2015.05.25
Kurma Partners announces the launch of its third fund Kurma Diagnostics (KDx)
The European Investment Fund (EIF), Fonds National d’Amorçage (FNA) managed by Bpifrance as part of the French government’s Investments for the future (“Investissements d’Avenir”) program, Institut Pasteur, and BNP Paribas are participating in the first closing (€33M). Kurma Diagnostics: the first Venture Capital fund dedicated to financing early-stage European...
